Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands

K Karampampa, A Gustavsson… - Journal of medical …, 2013 - Taylor & Francis
Background: Multiple sclerosis (MS) is an important, highly disabling neurological disease,
common among young adults in The Netherlands. Nevertheless, only a few studies to date …

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries

K Karampampa, A Gustavsson… - Multiple Sclerosis …, 2012 - journals.sagepub.com
Background: Multiple sclerosis (MS) is a common cause of neurological disability in young
adults. The TRIBUNE study provides a detailed exploration of costs in relation to relapses …

Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis

J Ruutiainen, AM Viita, J Hahl, J Sundell… - Journal of medical …, 2016 - Taylor & Francis
Objective: Although multiple sclerosis (MS) is one of the most common causes of non-
traumatic disability among young adults, no published data on its economic and health …

Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.

K Karampampa, A Gustavsson… - Journal of Population …, 2012 - europepmc.org
BACKGROUND: Multiple sclerosis (MS) is the most common neurological disease among
young adults in Canada, but few studies to date have measured the burden imposed by MS …

Costs and quality of life in multiple sclerosis in The Netherlands

G Kobelt, J Berg, P Lindgren - The European Journal of Health Economics, 2006 - Springer
This cost-of-illness analysis based on information from 1.549 patients in The Netherlands is
part of a Europe-wide study on the costs of multiple sclerosis (MS). The objective was to …

Costs and quality of life of multiple sclerosis in Switzerland

G Kobelt, J Berg, P Lindgren, A Gerfin, J Lutz - The European Journal of …, 2006 - Springer
This cost-of-illness analysis, based on information from 1101 patients in Switzerland, is part
of a Europe-wide cost-of-illness study in multiple sclerosis (MS). The objective was to …

New insights into the burden and costs of multiple sclerosis in Europe: results for the Netherlands

B Uitdehaag, G Kobelt, J Berg, D Capsa… - Multiple Sclerosis …, 2017 - journals.sagepub.com
Introduction: To estimate the value of interventions in multiple sclerosis (MS)–where lifetime
costs and outcomes cannot be observed–outcome data have to be combined with costs …

New insights into the burden and costs of multiple sclerosis in Europe: results for Switzerland

P Calabrese, G Kobelt, J Berg, D Capsa… - Multiple Sclerosis …, 2017 - journals.sagepub.com
Introduction: To estimate the value of interventions in multiple sclerosis (MS)–where lifetime
costs and outcomes cannot be observed–outcome data have to be combined with costs …

New insights into the burden and costs of multiple sclerosis in Europe: results for Germany

P Flachenecker, G Kobelt, J Berg… - Multiple Sclerosis …, 2017 - journals.sagepub.com
Introduction: To estimate the value of interventions in multiple sclerosis (MS)–where lifetime
costs and outcomes cannot be observed–outcome data have to be combined with costs …

Costs and quality of life for patients with multiple sclerosis in Belgium

G Kobelt - The European Journal of Health Economics, 2006 - Springer
This cost-of-illness analysis for Belgium is part of a Europe-wide study on the costs of
multiple sclerosis (MS). The objective was to analyze the costs and quality of life (QOL) …